Back to Search
Start Over
Pharmacological enhancement of repolarization reserve in human induced pluripotent stem cells derived cardiomyocytes.
- Source :
-
Biochemical pharmacology [Biochem Pharmacol] 2019 Nov; Vol. 169, pp. 113608. Date of Electronic Publication: 2019 Aug 26. - Publication Year :
- 2019
-
Abstract
- Background: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are used for many applications including safety pharmacology. However, a deficiency or complete absence of several K <superscript>+</superscript> currents suggests repolarization reserve is low in hiPSC-CMs. We determined whether a dual I <subscript>to</subscript> and I <subscript>Kr</subscript> activator can improve repolarization reserve in hiPSC-CMs resulting in a more electrophysiologically mature phenotype.<br />Methods and Results: Human iPSC were maintained on growth factor and differentiated into the cardiac phenotype by addition of selective Wnt molecules. Current and voltage clamp recordings in single cells were made using patch electrodes. Extracellular field potentials were made using a microelectrode array on hiPSC monolayers. Action potential recordings from hiPSC-CMs following application of an I <subscript>Kr</subscript> inhibitor resulted in depolarization of the membrane potential and prolongation of the APD. A flattening of the T-wave was noted on the pseudo-ECG. In contrast, application of the I <subscript>Kr</subscript> and I <subscript>to</subscript> agonist, NS3623, resulted in hyperpolarization of the membrane, slowing of the spontaneous rate and shortening of the APD. Voltage clamp recording showed a significant increase in I <subscript>Kr</subscript> ; no enhancement of I <subscript>to</subscript> in hiPSC-CMs was noted. AP clamp experiments revealed that I <subscript>Kr</subscript> plays a role in both phase 3 repolarization and phase 4 depolarization. mRNA analysis revealed that KCNH2 is abundantly expressed in hiPSC-CM, consistent with electrophysiological recordings.<br />Conclusions: Although NS3623 is a dual I <subscript>to</subscript> and I <subscript>Kr</subscript> activator in ventricular myocytes, application of this compound to hiPSC-CMs enhanced only I <subscript>Kr</subscript> and no effect on I <subscript>to</subscript> was noted. Our results suggest I <subscript>Kr</subscript> enhancement can improve repolarization reserve in this cell type. The disconnect between a dramatic increase in I <subscript>to</subscript> in adult myocytes versus the lack of effect in hiPSC-CMs suggest that the translation of pharmacological effects in hiPSC-CM to adult myocytes should be viewed with caution.<br /> (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Subjects :
- Action Potentials drug effects
Cell Differentiation
Cells, Cultured
Humans
Myocytes, Cardiac physiology
Phenylurea Compounds pharmacology
Piperidines pharmacology
Potassium Channels physiology
Pyridines pharmacology
Tetrazoles pharmacology
Induced Pluripotent Stem Cells cytology
Myocytes, Cardiac drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1873-2968
- Volume :
- 169
- Database :
- MEDLINE
- Journal :
- Biochemical pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 31465775
- Full Text :
- https://doi.org/10.1016/j.bcp.2019.08.010